|
1HCF
Crystal structure of TrkB-d5 bound to neurotrophin-4/5
Deposited 2001-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain X
286–383(98 aa)
Fragment:EXTRACELLULAR DOMAIN 5 (RESIDUES 286 - 383)
Chain Y
286–383(98 aa)
Fragment:EXTRACELLULAR DOMAIN 5 (RESIDUES 286 - 383)
|
Not recorded
|
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;10 MG/ML COMPLEX IN 20MM TRIS, 150MM NACL, PH 7.5, 100MM HEPES PH 7.5, 1.5M LISO4
|
Resolution 2.70 Å
R-free 0.264
|
|
1WWB
LIGAND BINDING DOMAIN OF HUMAN TRKB RECEPTOR
Deposited 1999-05-03
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
283–385(103 aa)
Fragment:LIGAND BINDING DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.5
|
Resolution 2.10 Å
R-free 0.297
|
|
2MFQ
NMR solution structures of FRS2a PTB domain with neurotrophin receptor TrkB
Deposited 2013-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
497–519(23 aa)
Fragment:UNP residues 497-519
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Pressure ambient
NMR sample composition
100 mM sodium phosphate, 5 mM [U-100% 2H] DTT, 0.5 mM [U-100% 2H] EDTA, 100% D2O | 100% D2O
NMR sample composition
100 mM sodium phosphate, 5 mM [U-100% 2H] DTT, 0.5 mM [U-100% 2H] EDTA, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
4ASZ
Crystal structure of apo TrkB kinase domain
Deposited 2012-05-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
543–838(296 aa)
Fragment:KINASE DOMAIN, RESIDUES 543-838
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;277 K;THE APO-TRKB PROTEIN WAS CONCENTRATED TO 6 MG/ML AND CRYSTALLIZED IN 3 M NA-FORMATE, PH 8.0 AT 4 DEGREES C.
|
Resolution 1.70 Å
R-free 0.203
|
|
4AT3
CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N
Deposited 2012-05-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
543–838(296 aa)
Fragment:KINASE DOMAIN, RESIDUES 543-838
|
Not recorded
|
LTI (5Z)-5-(carbamoylimino)-3-[(5R)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ylsulfanyl]-2,5-dihydroisothiazole-4-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;277 K;THE TRKB-CPD5N COMPLEX WAS OBTAINED BY COCRYSTALLIZATION IN 1.6 M AMMONIUM SULFATE, 50 MM MES, PH 6.0 AT 4 DEGREESC IN PRESENCE OF 2 MM OF INHIBITOR.
|
Resolution 1.77 Å
R-free 0.224
|
|
4AT4
CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH EX429
Deposited 2012-05-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
543–838(296 aa)
Fragment:KINASE DOMAIN, RESIDUES 543-838
|
Not recorded
|
T6E 1-[4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;277 K;THE TRKB-EX429 COMPLEX WAS OBTAINED BY COCRYSTALLIZATION IN 2.1 M NA-FORMATE, 50 MM HEPES, PH 8.0 AT 4 DEGREES C IN PRESENCE OF 1 MM OF INHIBITOR.
|
Resolution 2.36 Å
R-free 0.217
|
|
5MO9
Structure of human TrkB receptor ligand binding domain in complex with the Fab frgment of antibody AB20
Deposited 2016-12-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain X
278–426(149 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;6% w/v PEG 3350, 25 mM Tris pH 8.5
|
Resolution 2.59 Å
R-free 0.224
|
|
8OYD
TrkB transmembrane domain NMR structure in DMPC/DHPC bicelles
Deposited 2023-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
422–466(45 aa)
Chain B
422–466(45 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;313 K;Ionic strength (raw mmCIF value) 20;Pressure AMBIENT
NMR sample composition
5 % v/v [U-2H] D2O, 1.1 mM [U-100% 13C; U-100% 15N] High affinity receptor of neurotrophin-4 and brain-derived neurotrophic factor (TrkB), 9.6 mM [U-2H] DMPC, 42.7 mM [U-2H] DHPC, 1.0 mM n.a. TCEP, 0.01 % w/v n.a. sodium azide, 20.0 mM n.a. sodium phosphate buffer, 0.5 mM d4 TSP, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|